Logo image of SGHT

SIGHT SCIENCES INC (SGHT) Stock Fundamental Analysis

NASDAQ:SGHT - Nasdaq - US82657M1053 - Common Stock - Currency: USD

2.66  +0.05 (+1.92%)

After market: 2.66 0 (0%)

Fundamental Rating

3

SGHT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. While SGHT seems to be doing ok healthwise, there are quite some concerns on its profitability. SGHT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SGHT has reported negative net income.
SGHT had a negative operating cash flow in the past year.
In the past 5 years SGHT always reported negative net income.
SGHT had a negative operating cash flow in each of the past 5 years.
SGHT Yearly Net Income VS EBIT VS OCF VS FCFSGHT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

SGHT's Return On Assets of -36.06% is in line compared to the rest of the industry. SGHT outperforms 40.31% of its industry peers.
The Return On Equity of SGHT (-58.85%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -36.06%
ROE -58.85%
ROIC N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
SGHT Yearly ROA, ROE, ROICSGHT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

SGHT has a Gross Margin of 85.50%. This is amongst the best in the industry. SGHT outperforms 96.34% of its industry peers.
In the last couple of years the Gross Margin of SGHT has grown nicely.
SGHT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
SGHT Yearly Profit, Operating, Gross MarginsSGHT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

SGHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SGHT has been increased compared to 1 year ago.
Compared to 5 years ago, SGHT has more shares outstanding
The debt/assets ratio for SGHT is higher compared to a year ago.
SGHT Yearly Shares OutstandingSGHT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SGHT Yearly Total Debt VS Total AssetsSGHT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SGHT has an Altman-Z score of -1.48. This is a bad value and indicates that SGHT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SGHT (-1.48) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.45 indicates that SGHT is not too dependend on debt financing.
SGHT has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z -1.48
ROIC/WACCN/A
WACC9.73%
SGHT Yearly LT Debt VS Equity VS FCFSGHT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 9.04 indicates that SGHT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.04, SGHT belongs to the best of the industry, outperforming 90.05% of the companies in the same industry.
A Quick Ratio of 8.63 indicates that SGHT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 8.63, SGHT belongs to the best of the industry, outperforming 91.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.04
Quick Ratio 8.63
SGHT Yearly Current Assets VS Current LiabilitesSGHT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.65% over the past year.
The Revenue has decreased by -1.46% in the past year.
Measured over the past years, SGHT shows a very strong growth in Revenue. The Revenue has been growing by 27.88% on average per year.
EPS 1Y (TTM)9.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.55%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%1.72%

3.2 Future

SGHT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
Based on estimates for the next years, SGHT will show a small growth in Revenue. The Revenue will grow by 4.31% on average per year.
EPS Next Y-8.52%
EPS Next 2Y4.81%
EPS Next 3Y8.47%
EPS Next 5YN/A
Revenue Next Year-10.21%
Revenue Next 2Y-0.09%
Revenue Next 3Y4.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SGHT Yearly Revenue VS EstimatesSGHT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
SGHT Yearly EPS VS EstimatesSGHT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGHT. In the last year negative earnings were reported.
Also next year SGHT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGHT Price Earnings VS Forward Price EarningsSGHT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGHT Per share dataSGHT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y8.47%

More info and screens

0

5. Dividend

5.1 Amount

SGHT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGHT SCIENCES INC

NASDAQ:SGHT (4/17/2025, 8:00:02 PM)

After market: 2.66 0 (0%)

2.66

+0.05 (+1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-01 2025-05-01/amc
Inst Owners53.22%
Inst Owner Change0.03%
Ins Owners19.35%
Ins Owner Change7.13%
Market Cap136.54M
Analysts74.29
Price Target3.57 (34.21%)
Short Float %3.87%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.36%
Min EPS beat(2)-10.81%
Max EPS beat(2)-3.91%
EPS beat(4)1
Avg EPS beat(4)-3.72%
Min EPS beat(4)-17.36%
Max EPS beat(4)17.2%
EPS beat(8)5
Avg EPS beat(8)7.52%
EPS beat(12)7
Avg EPS beat(12)3.63%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.33%
Min Revenue beat(2)-5.54%
Max Revenue beat(2)-3.12%
Revenue beat(4)1
Avg Revenue beat(4)-1.94%
Min Revenue beat(4)-5.54%
Max Revenue beat(4)2.75%
Revenue beat(8)2
Avg Revenue beat(8)-2.41%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.54%
PT rev (3m)-33.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.78%
EPS NY rev (1m)-27.8%
EPS NY rev (3m)-35.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.46%
Revenue NY rev (1m)-10.64%
Revenue NY rev (3m)-17.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.71
P/FCF N/A
P/OCF N/A
P/B 1.56
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS1.56
BVpS1.71
TBVpS1.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.06%
ROE -58.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.5%
FCFM N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
F-Score3
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.07%
Cap/Sales 0.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.04
Quick Ratio 8.63
Altman-Z -1.48
F-Score3
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)106.51%
Cap/Depr(5y)124.16%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.55%
EPS Next Y-8.52%
EPS Next 2Y4.81%
EPS Next 3Y8.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%1.72%
Revenue Next Year-10.21%
Revenue Next 2Y-0.09%
Revenue Next 3Y4.31%
Revenue Next 5YN/A
EBIT growth 1Y11.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.08%
EBIT Next 3Y17.5%
EBIT Next 5YN/A
FCF growth 1Y52.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.63%
OCF growth 3YN/A
OCF growth 5YN/A